News

A new Human Pathology Atlas launched this month by researchers at Sweden’s national Science for Life Laboratory analyses all human genes in all major cancers, showing the consequence of their corresponding protein levels for overall patient survival

A scheme launched in 2011 to help patients stick to their drug regimens has been so successful that in its first five years it saved the National Health Service in England £75.4 million, and will save £517.6m in the longer-term

Strategy report calls for funding to create new industries, increased collaboration between pharmaceutical companies and the National Health Service, and incentives to keep the UK attractive to world class scientists after it leaves the EU

The euro may be strengthening but austerity still rules. Meeting the Lisbon target of spending 3% of GDP on research looks as remote as ever

The loan comes from Juncker’s European Fund for Strategic Investment and will be used to develop new cancer treatments

With the cost of building the European Spallation Source going at least €150M over budget, the facility will have to wait longer to reach full power

Günther Oettinger says research should be the only programme spared spending cuts as the EU weighs how to make up for losing the UK’s €11B per annum contribution